瑞普生物 (300119.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.5x

Market Cap

CNY 8.06B

MomentumView details →

1D Return

−3.24%

YTD Return

−5.75%

RSI (14)

51.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.5x

Market Cap

CNY 8.06B

RSI (14)

51.5

MomentumView details →

1D Return

−3.24%

YTD Return

−5.75%

ProfitabilityView details →

Gross Margin

40.91%

Net Margin

11.53%

EBITDA Margin

20.34%

ROE (TTM)

8.15%

ROA (TTM)

5.03%

Asset Turnover

0.44x

GrowthView details →

Revenue YoY

+6.11%

EPS YoY

+21.28%

FCF YoY

−86.07%

Revenue CAGR 3Y

+17.70%

EPS CAGR 3Y

+5.59%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.21

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.10%

Capital & dividendView details →

Debt/Equity

0.25x

Current Ratio

1.81x

Quick Ratio

1.54x

Div Yield

2.26%

Div Rate

CNY 0.40

Div Growth 1Y

+33.33%

Financials snapshotView financials →

Revenue (TTM)

3.40B

Net Income (TTM)

392.31M

Op. CF (TTM)

235.35M

Next earningsOct 28, 2026 →

Latest newsMore news →

Ruipu Biology announced that two avian influenza vaccines passed the Ministry of Agriculture and Rural Affairs' review for production strain change filing.4d ago

Ruipu Biology announced its 2026 first-half results: net profit attributable to shareholders was 204 million yuan, down 20.43% year-on-year, with revenue of 1.72 billion yuan, up 0.75%.10d ago

Similar companies

慕思股份001323.SZ 海安集团001233.SZ 银河磁体300127.SZ 银邦股份300337.SZ 奥尼电子301189.SZ 中南文化002445.SZ Find similar companies →

Latest newsMore news →

Ruipu Biology announced that two avian influenza vaccines passed the Ministry of Agriculture and Rural Affairs' review for production strain change filing.4d ago Ruipu Biology announced its 2026 first-half results: net profit attributable to shareholders was 204 million yuan, down 20.43% year-on-year, with revenue of 1.72 billion yuan, up 0.75%.10d ago